Keun You Kim
Overview
Explore the profile of Keun You Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
81
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Jang S, Choi S, Son S, Oh J, Ha J, Kim W, et al.
Front Psychiatry
. 2023 Feb;
13:1057513.
PMID: 36741575
Objectives: As the significance of the early diagnosis of mild cognitive impairment (MCI) has emerged, it is necessary to develop corresponding screening tools with high ecological validity and feasible biomarkers....
12.
13.
Kim K, Ha J, Kim M, Cho S, Kim H, Kim E
Alzheimers Res Ther
. 2022 Nov;
14(1):165.
PMID: 36329496
Background: Blood adiponectin and leptin are adipokines that emerged as potential biomarkers for predicting Alzheimer's disease (AD) owing to their strong connection with obesity. Although obesity affects the relation between...
14.
Kim K, Park J, Jeong Y, Kim H, Lee E, Park J, et al.
Alzheimers Res Ther
. 2022 Nov;
14(1):162.
PMID: 36324157
Background: Subjective cognitive decline (SCD) is a target for Alzheimer's disease prediction. Plasma amyloid-beta oligomer (AβO), the pathogenic form of Aβ in blood, has recently been proposed as a novel...
15.
Ha J, Kwak S, Kim K, Kim H, Cho S, Kim M, et al.
J Gerontol A Biol Sci Med Sci
. 2022 Feb;
78(1):120-128.
PMID: 35137074
Background: Adipokines such as leptin and adiponectin are associated with cognitive function. Although adiposity crucially affects adipokine levels, it remains unclear whether the relationship between adipokines and cognition is influenced...
16.
Ha J, Choi D, Kim K, Cho S, Kim H, Kim K, et al.
Sci Rep
. 2021 Dec;
11(1):24069.
PMID: 34912022
Metformin reduces insulin resistance, which constitutes a pathophysiological connection of diabetes with Alzheimer's disease (AD), but the evidence of metformin on AD development was still insufficient and conflicting. We investigated...
17.
Kim K, Kwak S, Ha J, Oh D, Kim M, Cho S, et al.
Psychoneuroendocrinology
. 2021 Dec;
136:105624.
PMID: 34902775
Background: Irisin, an exercise-induced myokine, has been shown to have beneficial effects on cognitive and metabolic functions. However, previous studies assessing the levels of circulating irisin in patients with Alzheimer's...
18.
Ha J, Choi D, Kim K, Nam C, Kim E
Cardiovasc Diabetol
. 2021 Jul;
20(1):152.
PMID: 34315501
Background: Pioglitazone use is known to be associated with a reduced risk of recurrent stroke in patients with diabetes mellitus (DM) who have a history of stroke. However, it is...